4.Other Assets
Other assets consisted of the following (in thousands):
December 31,
2025
2024
Clinical trial deposits
$
12,882
12,639
Deferred offering costs
709
—
Other
218
217
Total other assets
13,809
12,856
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
No definition available.